Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers

被引：0
|
作者：
T. Byrski
J. Gronwald
T. Huzarski
E. Grzybowska
M. Budryk
M. Stawicka
T. Mierzwa
M. Szwiec
R. Wiśniowski
M. Siolek
S. A. Narod
J. Lubinski
机构：
[1] Pomeranian Medical University,Department of Genetics and Pathology, International Hereditary Cancer Center
[2] Maria Sklodowska-Curie Memorial Institute,Department of Tumor Biology, Centre of Oncology
[3] Prophylactic and Epidemiology Center,Women’s College Research Institute
[4] Regional Oncology Hospital,undefined
[5] Regional Oncology Center,undefined
[6] Regional Oncology Hospital,undefined
[7] Holy Cross Oncology Center,undefined
[8] University of Toronto,undefined
来源：
Breast Cancer Research and Treatment | 2008年 / 108卷
关键词：
Taxane; Neo-adjuvant chemotherapy; BRCA1; Breast cancer; Doxorubicin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：289 / 296
页数：7
相关论文
共 50 条
  • [1] Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers
    Byrski, T.
    Gronwald, J.
    Huzarski, T.
    Grzybowska, E.
    Budryk, M.
    Stawicka, M.
    Mierzwa, T.
    Szwiec, M.
    Wisniowski, R.
    Siolek, M.
    Narod, S. A.
    Lubinski, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 108 (02) : 289 - 296
  • [2] Response to neo-adjuvant chemotherapy in BRCA1 and BRCA2 related stage III breast cancer
    Hubert, Ayala
    Mali, Bela
    Hamburger, Tamar
    Rottenberg, Yakir
    Uziely, Beatrice
    Peretz, Tamar
    Kadouri, Luna
    FAMILIAL CANCER, 2009, 8 (03) : 173 - 177
  • [3] Response to neo-adjuvant chemotherapy in BRCA1 and BRCA2 related stage III breast cancer
    Ayala Hubert
    Bela Mali
    Tamar Hamburger
    Yakir Rottenberg
    Beatrice Uziely
    Tamar Peretz
    Luna Kadouri
    Familial Cancer, 2009, 8 : 173 - 177
  • [4] Does response to neo-adjuvant chemotherapy impact breast reconstruction?
    Cassidy, Michael R.
    Zabor, Emily C.
    Stempel, Michelle
    Mehrara, Babak
    Gemignani, Mary L.
    BREAST JOURNAL, 2018, 24 (04) : 567 - 573
  • [5] Efficacy of neo-adjuvant chemotherapy with TEC regimen on breast cancer
    Gu, Xi
    Zhang, Yang
    Chen, Long
    Guo, Jiao
    Zhang, Wen-Hai
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (02) : 301 - 308
  • [6] Overuse of Neo-adjuvant Chemotherapy for Primary Breast Cancer
    Wadhwani, Nikita
    Jatoi, Ismail
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2020, 11 (01) : 12 - 14
  • [7] Overuse of Neo-adjuvant Chemotherapy for Primary Breast Cancer
    Nikita Wadhwani
    Ismail Jatoi
    Indian Journal of Surgical Oncology, 2020, 11 : 12 - 14
  • [8] Protein profiling predicts the response to anthracycline and taxanes based neo-adjuvant chemotherapy in breast cancer
    Wang, Shu
    Yang, Houpu
    Guo, Jiajia
    Liu, Miao
    Tong, Fuzhong
    Cao, Yingming
    Zhou, Bo
    Liu, Peng
    Liu, Hongjun
    Cheng, Lin
    Xie, Fei
    Yang, Deqi
    Zhang, Jiaqing
    BIOCHIP JOURNAL, 2011, 5 (01) : 32 - 38
  • [9] Exploring patient experiences of neo-adjuvant chemotherapy for breast cancer
    Beaver, Kinta
    Williamson, Susan
    Briggs, Jean
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2016, 20 : 77 - 86
  • [10] Efficacy of neo-adjuvant chemotherapy with TEC regimen on breast cancer
    Xi Gu
    Yang Zhang
    Long Chen
    Jiao Guo
    Wen-Hai Zhang
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 301 - 308
12345